Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Diseases × Atorvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Prostatic Neoplasms 9 Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myeloid, Acute 4 Myelodysplastic Syndromes 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Cardiovascular Diseases 3 Cardiotoxicity 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Heart Failure 2 Glioblastoma 2 Endometrial Hyperplasia 2 Colorectal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Venous Thrombosis 1 Smoking 1 Pulmonary Disease, Chronic Obstructive 1 Precancerous Conditions 1 Overall Survival 1 Ototoxicity 1 Neoplastic Cells, Circulating 1

Interventions

Nutrition Assessment 2 Echocardiography 2 Blood Specimen Collection 2 Antineoplastic Agents 2 liposomal doxorubicin 1 Vitamin E 1 Vital Signs 1 Tomography, X-Ray Computed 1 Tomography, Emission-Computed 1 Surveys and Questionnaires 1 Specimen Handling 1 Positron-Emission Tomography 1 Methods 1 Mass Screening 1 Magnetic Resonance Imaging 1 Interviews as Topic 1 Immunomodulating Agents 1 Immune Checkpoint Inhibitors 1 Hematologic Tests 1 Exercise Test 1 Educational Status 1 Diagnosis 1 Case Management 1 Breathing Exercises 1 Atorvastatin 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02674204 2019-05-15

STOP

Cedars-Sinai Medical Center

Phase 2 Terminated

2 enrolled 7 charts

Breast Neoplasms, Heart Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡